Oligonucleotides specific for the marORAB operon
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 24, 2000
Issued Date -
N/A
app pub date -
Feb 20, 1998
filing date -
Feb 21, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are synthetic oligonucleotides complementary to a transcript of the marORAB operon which inhibit expression of a gene in the operon. Also disclosed are methods of reducing bacterial resistance to antibiotics, and pharmaceutical formulations containing marORAB-specific oligonucleotides of the invention.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully